avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr1h4
|
ENSMUSG00000047638.9 | nuclear receptor subfamily 1, group H, member 4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nr1h4 | mm10_v2_chr10_-_89506631_89506658 | 0.88 | 9.1e-13 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 13.3 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
2.9 | 11.6 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.3 | 14.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
2.2 | 30.9 | GO:0006751 | glutathione catabolic process(GO:0006751) |
2.2 | 10.8 | GO:0015886 | heme transport(GO:0015886) |
1.9 | 17.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.7 | 10.0 | GO:0046618 | drug export(GO:0046618) |
1.6 | 6.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
1.3 | 8.9 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
1.2 | 3.5 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
1.1 | 3.4 | GO:0006507 | GPI anchor release(GO:0006507) |
1.1 | 5.5 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
1.1 | 5.3 | GO:0032827 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
1.0 | 2.9 | GO:1902071 | positive regulation of cellular response to hypoxia(GO:1900039) regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
1.0 | 2.9 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.9 | 3.6 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.8 | 5.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.8 | 4.7 | GO:1903275 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
0.7 | 9.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.7 | 9.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.6 | 2.4 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.6 | 6.5 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.6 | 5.9 | GO:0015879 | carnitine transport(GO:0015879) |
0.6 | 1.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.6 | 9.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.5 | 3.1 | GO:0060523 | Sertoli cell proliferation(GO:0060011) prostate epithelial cord elongation(GO:0060523) |
0.5 | 4.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.5 | 1.5 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.5 | 4.7 | GO:1900194 | receptor guanylyl cyclase signaling pathway(GO:0007168) negative regulation of oocyte maturation(GO:1900194) |
0.5 | 1.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 3.3 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.5 | 1.8 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.5 | 1.4 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.4 | 4.4 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.4 | 2.0 | GO:0060296 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.4 | 4.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 1.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.4 | 5.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 1.0 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 1.7 | GO:0048597 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 1.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.3 | 1.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 3.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 0.9 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.2 | 1.5 | GO:0042737 | drug catabolic process(GO:0042737) |
0.2 | 7.0 | GO:0071625 | vocalization behavior(GO:0071625) |
0.2 | 1.5 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.8 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.2 | 2.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 13.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.2 | 2.8 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.2 | 15.4 | GO:0070206 | protein trimerization(GO:0070206) |
0.2 | 9.9 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 2.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 0.8 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 1.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 1.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 1.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 1.9 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 5.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 0.9 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 0.8 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 1.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 2.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 11.2 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.1 | 0.8 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 3.3 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.5 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.1 | 1.7 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 5.9 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 4.3 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.1 | 0.2 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.1 | 0.6 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 0.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 1.7 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 2.4 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 0.7 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 1.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 2.0 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 2.9 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.1 | GO:0060075 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) regulation of resting membrane potential(GO:0060075) |
0.0 | 2.1 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 2.1 | GO:0006096 | glycolytic process(GO:0006096) |
0.0 | 0.6 | GO:0006903 | vesicle targeting(GO:0006903) |
0.0 | 3.7 | GO:0007596 | blood coagulation(GO:0007596) |
0.0 | 1.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 1.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.8 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 1.7 | GO:0043627 | response to estrogen(GO:0043627) |
0.0 | 1.4 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 0.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 1.1 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 2.9 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.1 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.0 | GO:0006657 | CDP-choline pathway(GO:0006657) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 7.0 | GO:0097513 | myosin II filament(GO:0097513) |
0.8 | 10.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.5 | 11.6 | GO:0042627 | chylomicron(GO:0042627) |
0.4 | 3.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.4 | 6.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 3.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.3 | 2.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 2.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 4.8 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 35.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 1.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 4.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 2.0 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 8.9 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 13.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 14.0 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.2 | 1.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 5.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 3.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 0.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 1.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 9.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 2.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.6 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 3.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 1.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 9.2 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 4.3 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 9.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.0 | 6.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 1.6 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 1.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 1.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 1.2 | GO:0000786 | nucleosome(GO:0000786) |
0.0 | 9.2 | GO:0005740 | mitochondrial envelope(GO:0005740) |
0.0 | 0.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 8.9 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
2.7 | 10.8 | GO:0015232 | heme transporter activity(GO:0015232) |
2.6 | 30.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
2.3 | 14.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.6 | 6.5 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.6 | 33.0 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
1.4 | 11.6 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.1 | 5.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
1.0 | 3.1 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
1.0 | 5.9 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.9 | 4.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.8 | 3.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.7 | 3.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.6 | 2.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 5.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.6 | 1.7 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.5 | 6.6 | GO:0016918 | retinal binding(GO:0016918) |
0.5 | 4.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.5 | 4.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.4 | 11.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.4 | 3.5 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 3.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 7.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 1.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 1.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.3 | 1.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.2 | 1.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 1.7 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.2 | 7.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 2.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 13.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 1.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 4.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 0.5 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.2 | 2.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 1.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 29.0 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.2 | 0.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 2.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 4.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 3.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 3.6 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 2.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.3 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 2.1 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 2.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 1.4 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 6.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 4.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 5.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 15.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 16.5 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.1 | 0.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 1.6 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 1.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 1.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 2.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 1.8 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 1.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 1.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 2.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.1 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 1.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 1.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 1.8 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 2.9 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 2.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.6 | GO:0017171 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
0.0 | 1.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 1.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 1.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 16.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 9.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 35.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 3.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 4.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 3.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 6.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 1.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 1.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 1.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 13.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
1.0 | 14.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.6 | 14.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 10.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.5 | 4.1 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 6.5 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.4 | 11.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 4.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 5.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 4.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 4.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 7.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 1.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 14.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 1.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 3.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 1.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 2.8 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 2.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 2.5 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 5.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 1.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |